No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Dacarbazine / administration & dosage
-
Dacarbazine / adverse effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Follow-Up Studies
-
Hodgkin Disease / drug therapy*
-
Hodgkin Disease / mortality
-
Humans
-
Mechlorethamine / administration & dosage
-
Mechlorethamine / adverse effects
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
Procarbazine / administration & dosage
-
Procarbazine / adverse effects
-
Survival Analysis
-
Vinblastine / administration & dosage
-
Vinblastine / adverse effects
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
Bleomycin
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
MOPP protocol